Skip to content

Depression: all studies

Page 825 of 1,035: studies 8,241 to 8,250 of 10,348, newest first. Back to the depression overview

Research

Longitudinal associations of nightmare frequency and nightmare distress with suicidal behavior in adolescents: mediating role of depressive symptoms

Sleep July 2, 2020 Xianchen Liu, Yanyun Yang, Zhenzhen Liu et al. 41 citations

STUDY OBJECTIVES: Nightmares are a significant risk factor of suicidal behavior. This study examined the longitudinal associations of nightmare frequency and distress with suicidal thought (ST), suicide plan (SP), and suicide attempt (SA) and mediating role of depressive symptoms in adolescents. METHODS: A total of 6,923 adolescents who participated in the 1-year follow-up of Shandong...

Synthesis and characterization of high‐purity N,N‐dimethyltryptamine hemifumarate for human clinical trials

Drug Testing and Analysis July 1, 2020 Nicholas V. Cozzi, Paul F. Daley 12 citations

Abstract Since 2006, there has been a resurgent interest in the pharmacology and therapeutics of psychedelic drugs. Psilocybin, the 4‐phosphoryl ester of N,N ‐dimethyltryptamine (DMT), has been studied most often, but DMT itself is also appealing because of its brief but profound psychological effects and its presence as an endogenous substance in mammalian brain. Although there have been a few...

DOI: 10.1002/dta.2889 (opens in new tab) X-ray powder diffraction Alane Aluminum hydride Pharmaceutical synthesis +12

Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.

Biochemical Pharmacology July 1, 2020 Kenji Hashimoto 232 citations

Ketamine, an anesthetic developed in the early 1960s, is also a popular abused drug among young people at dance parties and raves and among spiritual seekers, because it produces schizophrenia-like symptoms and dissociation (i.e., out-of-body experience). Regarding mood disorders, ketamine exerts robust antidepressant actions in treatment-resistant patients with depression. Ketamine is a...

DOI: 10.1016/j.bcp.2020.113935 (opens in new tab) Full text (opens in new tab) R-ketamine or arketamine S-ketamine or esketamine Brain-gut-microbiota axis Brain-spleen axis +1

Molecular mechanisms for the antidepressant-like effects of a low-dose ketamine treatment in a DFP-based rat model for Gulf War Illness.

Neurotoxicology June 24, 2020 A. C. Ribeiro, Jackie Zhu, Mohamad M. Kronfol et al.

Exposure to organophosphates (OP) during the First Gulf War is among one of the factors for Gulf War Illness (GWI) development in veterans and it has been challenging to treat GWI symptoms with existing therapies. Ketamine produces a rapid-onset and sustained antidepressant response, but there is no evidence whether ketamine treatment is effective for GWI depression. Repeated, low-dose exposure...

Using Mind-Body Modalities via Telemedicine during the COVID-19 Crisis: Cases in the Republic of Korea.

International Journal of Environmental Research and Public Health June 22, 2020 Chan-Young Kwon, Hui-Yong Kwak, Jong Woo Kim

The coronavirus disease 2019 (COVID-19) pandemic affected the world, and its deleterious effects on human domestic life, society, economics, and especially on human mental health are expected to continue. Mental health experts highlighted health issues this pandemic may cause, such as depression, anxiety, obsessive compulsive disorder, and post-traumatic stress disorder. Mind-body intervention,...

DOI: 10.3390/ijerph17124477 (opens in new tab) Full text (opens in new tab) Anxiety Humans Pneumonia, viral Coronavirus infections +10

Effect of duloxetine acute treatment against 3, 4 methylenedioxymethamphetamine-induced cognitive impairment and memory deficiency in male rats

Avicenna Journal of Neuro Psycho Physiology June 22, 2020

Background and Aims: 3, 4- methylenedioxymethamphetamine (MDMA) is used for recreational purposes worldwide. The use of MDMA resulted in learning and memory dysfunction. Duloxetine, a serotonin/noradrenalin-reuptake inhibitor is also utilized to treat depression and anxiety. The current study aimed to evaluate the effects of duloxetine against MDMAchr('39')s effect on anxiety, cognition, and...

Party drug to mainstream medicine; the transition of ketamine

Sri Lanka Journal of Psychiatry June 18, 2020 Nisha Ravindran, Arun Ravindran

A significant proportion of patients with major depressive disorder are refractory to approved interventions. The first report of significant and rapid benefit of intravenous (IV) ketamine for treatment resistant depression (TRD) appeared in 2000. Since then, there have been multiple reports on the efficacy and tolerability of ketamine formulations for TRD, in particular for single-dose IV...

Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence

Expert Opinion on Drug Safety June 15, 2020 Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz et al. 50 citations

ABSTRACT Objectives Rigorous clinical trials suggest ketamine is safe and well-tolerated in patients with treatment-resistant depression (TRD). There is a paucity of data on the safety and tolerability of ketamine in community-based clinics treating patients with TRD. Methods Retrospective data was analyzed from 203 patients with TRD who received repeat-dose IV ketamine. Safety was...

Subanesthetic ketamine exerts antidepressant-like effects in adult rats exposed to juvenile stress.

Brain Research June 13, 2020 Katsuhiro Aikawa, Takayuki Yoshida, Yu Ohmura et al.

Juvenile stress, like that caused by childhood maltreatment, is a significant risk factor for psychiatric disorders such as depression later in life. Recently, the antidepressant effect of ketamine, a noncompetitive N-methyl-d-aspartate receptor antagonist, has been widely investigated. However, little is known regarding its efficacy against depressive-like alterations caused by juvenile...

The Dynamic Universal Profiles of Spiritual Awareness: A Latent Profile Analysis

Religions June 12, 2020 Simon Hanseung Choi, Clayton H. Mcclintock, Elsa Nga Sze Lau et al. 8 citations

The aim of the current investigation was to identify universal profiles of lived spirituality. A study on a large sample of participants (N = 5512) across three countries, India, China, and the United States, suggested there are at least five cross-cultural phenotypic dimensions of personal spiritual capacity—spiritual reflection and commitment; contemplative practice; perception of...